Trademark: 97120591
Word
SOLTYNLAZ
Status
Registered
Status Code
700
Status Date
Tuesday, December 13, 2022
Serial Number
97120591
Registration Number
6923994
Registration Date
Tuesday, December 13, 2022
Mark Type
4000
Filing Date
Thursday, November 11, 2021
Published for Opposition
Tuesday, September 27, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Oct 6, 2023
Teas Change Of Correspondence Received
Oct 6, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 6, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 6, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2023
Teas Change Of Owner Address Received
Dec 13, 2022
Notice Of Registration Confirmation Emailed
Dec 13, 2022
Registered-Principal Register
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 27, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 27, 2022
Published For Opposition
Sep 7, 2022
Notification Of Notice Of Publication E-Mailed
Aug 23, 2022
Approved For Pub - Principal Register
Aug 23, 2022
Assigned To Examiner
Nov 18, 2021
New Application Office Supplied Data Entered
Nov 15, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24